AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 39,000 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 10, 2026 · Filed Nov 12, 2026

On Nov 10, 2026, Equels Thomas K (Director, CEO & President) bought 39,000 AIM ImmunoTech Inc. shares at US$0.14 for US$5,382, leaving 293,095 shares. Filed Nov 12, 2026 (Form 4).

Bought
39,000 shares
Price
US$0.14
Value
US$5,382
Holding after
293,095 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 10, 2026Common StockBuy39,000US$0.14293,095Direct

Source

Download original · View original at SEC

Related